Cargando…
Current advances in the selection of adjuvant radiotherapy regimens for keloid
Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is most...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679021/ https://www.ncbi.nlm.nih.gov/pubmed/36425105 http://dx.doi.org/10.3389/fmed.2022.1043840 |
_version_ | 1784834120455553024 |
---|---|
author | Wang, Weihao Zhao, Jiang Zhang, Chi Zhang, Wanqi Jin, Manqiu Shao, Ying |
author_facet | Wang, Weihao Zhao, Jiang Zhang, Chi Zhang, Wanqi Jin, Manqiu Shao, Ying |
author_sort | Wang, Weihao |
collection | PubMed |
description | Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is mostly used in clinical treatment. Adjuvant radiotherapy is currently one of the most effective treatments for keloid. After long-term clinical practice, brachytherapy and electron beam radiotherapy has increasingly become the gold standard of treatment, because brachytherapy provides more focused radiation treatment to focal tissue to significantly reduce recurrence rate, and better preserve normal tissue. With the development of new radiotherapy techniques, more options for the treatment of keloid. Currently, adjuvant radiotherapy has been widely recognized, but there is no consensus on the optimal protocol for adjuvant radiotherapy for keloids. This review provides a review of published treatment options and new radiotherapy techniques for adjuvant radiotherapy of keloids and gives a comprehensive evaluation for clinical treatment. |
format | Online Article Text |
id | pubmed-9679021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96790212022-11-23 Current advances in the selection of adjuvant radiotherapy regimens for keloid Wang, Weihao Zhao, Jiang Zhang, Chi Zhang, Wanqi Jin, Manqiu Shao, Ying Front Med (Lausanne) Medicine Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is mostly used in clinical treatment. Adjuvant radiotherapy is currently one of the most effective treatments for keloid. After long-term clinical practice, brachytherapy and electron beam radiotherapy has increasingly become the gold standard of treatment, because brachytherapy provides more focused radiation treatment to focal tissue to significantly reduce recurrence rate, and better preserve normal tissue. With the development of new radiotherapy techniques, more options for the treatment of keloid. Currently, adjuvant radiotherapy has been widely recognized, but there is no consensus on the optimal protocol for adjuvant radiotherapy for keloids. This review provides a review of published treatment options and new radiotherapy techniques for adjuvant radiotherapy of keloids and gives a comprehensive evaluation for clinical treatment. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9679021/ /pubmed/36425105 http://dx.doi.org/10.3389/fmed.2022.1043840 Text en Copyright © 2022 Wang, Zhao, Zhang, Zhang, Jin and Shao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Wang, Weihao Zhao, Jiang Zhang, Chi Zhang, Wanqi Jin, Manqiu Shao, Ying Current advances in the selection of adjuvant radiotherapy regimens for keloid |
title | Current advances in the selection of adjuvant radiotherapy regimens for keloid |
title_full | Current advances in the selection of adjuvant radiotherapy regimens for keloid |
title_fullStr | Current advances in the selection of adjuvant radiotherapy regimens for keloid |
title_full_unstemmed | Current advances in the selection of adjuvant radiotherapy regimens for keloid |
title_short | Current advances in the selection of adjuvant radiotherapy regimens for keloid |
title_sort | current advances in the selection of adjuvant radiotherapy regimens for keloid |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679021/ https://www.ncbi.nlm.nih.gov/pubmed/36425105 http://dx.doi.org/10.3389/fmed.2022.1043840 |
work_keys_str_mv | AT wangweihao currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid AT zhaojiang currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid AT zhangchi currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid AT zhangwanqi currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid AT jinmanqiu currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid AT shaoying currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid |